Liz Logan, Head of the MCT-Congress, gives Journal for Clinical Studies an insight into the business of mobile technology in the clinical trial space, and …
Digitalization of healthcare is unstoppable, as it provides increased adherence, better health outcomes and – ultimately – billions of pounds saved worldwide. However, one vital …
The growing complexities of the drug development process, toughening drug safety standards, increased regulatory scrutiny, and ongoing patent cliff have placed significant pressure on the …
With continued efforts to improve clinical processes, risk-based monitoring (RBM) approaches are becoming increasingly important for sponsors and CROs. Petra Cramer of eClinical Data Services, …
In recent years, behavioural health agencies have begun to apply the outcomes-based measurements found in medicine to improve their ability to meet compliance standards via …
Martin Lamb of Biotec Services International proves there are ways in which a little extra time spent on up-front planning of clinical supply accountability can …
Currently, the global biosimilars market includes monoclonal antibody (mAb) biosimilars for the treatment of cancer and autoimmune conditions (e.g., rheumatoid arthritis), as well as insulin’s, …
Owing to a large population base, the prevalence of various dermatological disorders in India is fairly high, even for uncommon disorders. Vandana Mungroo Beechoo and …
With a bustling population composed of a mixture of expats and locals, and the topic of clinical research not being so popular among the crowd, …
Currently more than 45% of the whole continent’s clinical trials are being conducted in South Africa, hence the need for pharmaceutical companies to identify the …
Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.
